000 01202 a2200325 4500
005 20250518093523.0
264 0 _c20210621
008 202106s 0 0 eng d
022 _a1523-1755
024 7 _a10.1016/j.kint.2019.12.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCrickx, Etienne
245 0 0 _aAnti-CD20-mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives.
_h[electronic resource]
260 _bKidney international
_c05 2020
300 _a885-893 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntigens, CD20
650 0 4 _aAutoimmune Diseases
_xtherapy
650 0 4 _aB-Lymphocytes
650 0 4 _aHumans
650 0 4 _aLupus Erythematosus, Systemic
650 0 4 _aLymphocyte Depletion
650 0 4 _aRituximab
_xtherapeutic use
700 1 _aWeill, Jean-Claude
700 1 _aReynaud, Claude-Agnès
700 1 _aMahévas, Matthieu
773 0 _tKidney international
_gvol. 97
_gno. 5
_gp. 885-893
856 4 0 _uhttps://doi.org/10.1016/j.kint.2019.12.025
_zAvailable from publisher's website
999 _c30796894
_d30796894